10-K Decoder · All companies

Puma Biotechnology, Inc.

PBYI · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$228M$230M−0.9%
Operating income$37.3M$31.0M+20.4%
Net income$31.1M$30.3M+2.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$55.1M$54.5M+1.1%
Operating income$5.30M$9.60M−44.8%
Net income$6.00M$8.80M−31.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Puma Biotechnology's revenue in FY2025?
$228M in FY2025 (Fiscal year ended Dec 31, 2025), −0.9% vs $230M a year earlier, per its 10-K filed Feb 2026.
Was Puma Biotechnology profitable in FY2025?
Yes: net income was $31.1M and operating income $37.3M in FY2025.
What was Puma Biotechnology's revenue in Q3 2026?
$55.1M (+1.1% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.